BridgeMD
New treatment option for Lung Diseases, Interstitial
Official title A Randomised Clinical Trial of a Digital Self-management Package for People With Interstitial Lung Disease
ClinicalTrials.gov ID: NCT06122233
What this study is testing
- What it's testing
- The goal of this clinical trial is to compare REBUILD-SM (a purpose-built smartphone app and self-management package) with standard care in people with interstitial lung disease (ILD). The main question it aims to answer is: Does REBUILD-SM improve health-related quality of life, symptoms, anxiety, self-efficacy and physical activity for people with ILD?
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Diagnosis of fibrotic ILD
- In possession of a smartphone/tablet and an email address
- Able to understand written and spoken English
- Adequate digital literacy to complete requirements of trial
- On stable ILD treatment for 30 days prior to enrolment
You likely can't join if
- Not in possession of a smartphone/tablet
- Insufficient digital literacy to complete requirements of trial
- Unable to communicate in written/spoken English
- Not on stable ILD treatment for 30 days prior to enrolment
- Acute exacerbation within 30 days prior to enrolment
- Participating in pulmonary rehab at enrolment or during 12-week intervention period
See the full eligibility criteria
- Diagnosis of fibrotic ILD
- In possession of a smartphone/tablet and an email address
- Able to understand written and spoken English
- Adequate digital literacy to complete requirements of trial
- On stable ILD treatment for 30 days prior to enrolment
- Not in possession of a smartphone/tablet
- Insufficient digital literacy to complete requirements of trial
- Unable to communicate in written/spoken English
- Not on stable ILD treatment for 30 days prior to enrolment
- Acute exacerbation within 30 days prior to enrolment
- Participating in pulmonary rehab at enrolment or during 12-week intervention period
- Unable to provide informed consent
The study team makes the final eligibility decision.
Where it's taking place
- Sydney, New South Wales, Australia
- Brisbane, Queensland, Australia
- Melbourne, Victoria, Australia
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Sydney, New South Wales, Australia; Brisbane, Queensland, Australia; Melbourne, Victoria, Australia. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.